U.S. Stock Market Movement: Twist Bioscience Surges on October 28 Driven by New Antibody Screening, AI Drug Discovery, and High-Throughput Detection

Interpretation of Twist Bioscience's Surge on October 28

Keywords: New antibody screening, AI drug discovery, high-throughput testing

On October 28, Twist Bioscience launched Twist Express Screening Antibodies, enabling the evaluation of thousands of antibodies per day. The service turnaround time is as short as approximately 5 days, with offerings including full-length IgG purification and SPR binding characteristic analysis. This is aimed at AI/machine learning-driven discovery processes.

(Disclaimer: This content is summarized from publicly available information by AI technology for reference only and does not constitute investment advice.)